Taro Pharmaceutical Indus TARO reported its Q3 earnings results on Thursday, January 27, 2022 at 04:00 PM.
Here's what investors need to know about the announcement.
Taro Pharmaceutical Indus missed estimated earnings by 23.08%, reporting an EPS of $0.7 versus an estimate of $0.91, which surprised analysts.
Revenue was up $1.15 million from the same period last year.
Past Earnings Performance
Last quarter the company missed on EPS by $0.36, which was followed by a 7.14% drop in the share price the next day.
Here's a look at Taro Pharmaceutical Indus's past performance:
|Quarter||Q2 2022||Q1 2022||Q4 2021||Q3 2021|
To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.